Arama Sonuçları - Richard Honeywell

Subcellular localization of several structurally different tyrosine kinase inhibitors Yazar: Richard Honeywell, Sarina Hitzerd, Ietje Kathmann, Godefridus Peters

Connect to this object online.

Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors Yazar: Richard Honeywell, Christien Fatmawati, Marita Buddha, Sarina Hitzerd, Ietje Kathman, Godefridus Peters

Connect to this object online.

Adherence and patients' experiences with the use of capecitabine in daily practice Yazar: Lonneke Timmers, Christel Boons, Dirk Mangnus, Peter van de Ven, Pieter van den Berg, Aart Beeker, Eleonora Swart, Richard Honeywell, Godefridus Peters, Epie Boven, Jacqueline Hugtenburg, Jacqueline Hugtenburg

Connect to this object online.

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study Yazar: Imke H. Bartelink, Pierre M. Bet, Nicolas Widmer, Monia Guidi, Erik Duijvelaar, Bram Grob, Richard Honeywell, Amanda Evelo, Ivo P. E. Tielbeek, Sue D. Snape, Henrike Hamer, Laurent A. Decosterd, Harm Jan Bogaard, Jurjan Aman, Eleonora L. Swart

Connect to this object online.